Wendy van de Sande

Erasmus University Rotterdam

Research Interests

Explore related searches

Contact this professor

Google Scholar

Recent Grants

Grant: Close

Open Date: 2022-10-01

Close Date: 2023-12-01

Grant: Close

Point of care diagnostic test for mycetoma

Open Date: 2022-01-01

Close Date: 2025-12-01

Grant: Close

Open Date: 2020-01-01

Close Date: 2022-01-01

Grant: Close

Study the efficacy of fosravuconazole as a potential new, safe, and affordable treatment for patients with eumycetoma

Open Date: 2015-01-01

Close Date: 2022-01-01

Articles (30)

Collaborators (14)

Israel Cruz

Head International Health Department

Instituto de Salud Carlos III

Paul Turner

University of Oxford

UNITED KINGDOM

Geraint Davies

Professor of Infection Pharmacology

University of Liverpool

UNITED KINGDOM

Tanya Applegate

Senior Lecturer

University of New South Wales

Bernhard Biersack

H Rogier van Doorn

University of Oxford

UNITED KINGDOM

Kate Baker

University of Cambridge

UNITED KINGDOM

Yasushi Okazaki

Professor, Director

Juntendo University

Imad Abugessaisa

Osaka University

Mark Nicol

University of Western Australia

David Chandler

UNITED KINGDOM

Phoebe CM Williams

The University of Sydney School of Public Health

Emmanuel Edwar Siddig

Prasad Dandawate

University of Kansas Medical Center

UNITED STATES

Wendy van de Sande

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (30)

Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella

Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug Auranofin

Antiparasitic and Antifungal Activities of Cetyl-Maritima, a New N-Cetyl-Modified Maritima Derivative

A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-κB inhibitors active against eumycetoma

Kinome analysis of Madurella mycetomatis identified kinases in the cell wall integrity pathway as novel potential therapeutic drug targets in eumycetoma caused by Madurella mycetomatis

Madurella tropicana and Madurella pseudomycetomatis identified as new causative agents of black grain eumycetoma in Senegal

Eumycetoma

Ibrexafungerp prolongs survival and reduces the eumycetoma grain size in Galleria mellonella infection models of two different causative agents of eumycetoma

The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma

Development of the Mycetoma Activity and Severity clinical Scale (MASS)

WHO global research priorities for antimicrobial resistance in human health

WHO global research priorities for antimicrobial resistance in human health

Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan

Emerging Therapeutics

In Vitro and In Vivo Wide-Spectrum Dual Antimycetomal Activity of Eight Essential Oils Coupled with Chemical Composition and Metabolomic Profiling

Superior Anticancer and Antifungal Activities of New Sulfanyl-Substituted Niclosamide Derivatives

Eumycetoma causative agents

Novel Compound MMV1804559 from the Global Health Priority Box Exhibits In Vitro and In Vivo Activity against <i>Madurella mycetomatis</i>

The performance and costs of XTT, resazurin, MTS and luciferin as viability dyes in in vitro susceptibility testing of Madurella mycetomatis.

An updated list of eumycetoma causative agents and their differences in grain formation and treatment response.

A Falciformispora senegalensis grain model in Galleria mellonella larvae.

The First Case of <i>Fusarium falciforme</i> Eumycetoma in Sudan and an Extensive Literature Review about Treatment Worldwide

An update on the development of novel antifungal agents for eumycetoma

Antifungal Activity of Natural Naphthoquinones and Anthraquinones Against Madurella mycetomatis.

Evaluation of the antiparasitic and antifungal activities of new synthetic piperlongumine-type cinnamide derivatives: booster effect by halogen substituents.

Using a Madurella mycetomatis specific PCR on grains obtained via non-invasive Fine Needle Aspirated material is more accurate than cytology.

Comparing the performance of the common used eumycetoma diagnostic tests.

Diagnostics to support mycetoma management-Development of two target product profiles.

Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma

Staphylococcus aureus causing primary foot Botryomycosis mimicking actinomycetoma: a case report from Sudan.

Collaborators (14)

Israel Cruz

Paul Turner

Geraint Davies

Tanya Applegate

Bernhard Biersack

H Rogier van Doorn

Kate Baker

Yasushi Okazaki

Imad Abugessaisa

Mark Nicol

David Chandler

Phoebe CM Williams

Emmanuel Edwar Siddig

Prasad Dandawate

How do I reach out?

Meet Kite AI